UH
ABMD

Unigestion Holding’s Abiomed Inc ABMD Stock Holding History

Unigestion Holding’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,984
Closed -$980K – 220
2022
Q1 		$980K Hold
2,984
– – 0.04% 143
2021
Q4 		$1.07M Sell
2,984
-497
-14% -$168K 0.04% 145
2021
Q3 		$1.13M Sell
3,481
-955
-22% -$324K 0.05% 129
2021
Q2 		$1.39M Sell
4,436
-158
-3% -$48.5K 0.05% 123
2021
Q1 		$1.47M Buy
4,594
+3,840
+509% +$1.23M 0.05% 126
2020
Q4 		$244K Sell
754
-125
-14% -$34.6K 0.01% 216
2020
Q3 		$244K Buy
+879
New +$253K 0.01% 181
2020
Q2 		– Sell
-2,367
Closed -$344K – 278
2020
Q1 		$344K Buy
+2,367
New +$393K 0.01% 219
2019
Q1 		– Sell
-2,206
Closed -$717K – 312
2018
Q4 		$717K Buy
+2,206
New +$766K 0.02% 252

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Unigestion Holding's ABMD Position: Q2 2022 in Review

Unigestion Holding sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 2,984 shares — an estimated $980K sold.

Unigestion Holding first reported a position in ABMD in Q4 2018 and held it in 9 quarters. The position peaked at $1.47M in Q1 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Unigestion Holding reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • Unigestion Holding sold 2,984 Abiomed Inc shares in Q2 2022, an estimated $980K.
  • Unigestion Holding first reported a position in Abiomed Inc in Q4 2018 and held it in 9 quarters.
  • Unigestion Holding's Abiomed Inc position peaked at $1.47M in Q1 2021.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Unigestion Holding's 13F filing for Q2 2022, filed 3 Aug 2022.